Progress being made toward Mo-99 production at Darlington

September 29, 2020, 12:25PMNuclear News

Darlington nuclear generating station. Photo: OPG

Ontario Power Generation, its subsidiary Laurentis Energy Partners, and BWXT ITG Canada and its affiliates announced on September 24 that the companies are making “significant progress” toward the production of molybdenum-99 at OPG’s Darlington nuclear power plant. Darlington will become the first commercial operating nuclear reactor to produce the medical radioisotope.

A precursor to technetium-99m, Mo-99 is used in more than 40 million procedures a year to detect cancers and diagnose various medical conditions.

To continue reading, log in or create a free account!

Related Articles

BWXT announces nuclear manufacturing plant expansion

Investment banking on higher demand for SMR and large nuclear reactors

April 19, 2024, 9:30AMNuclear News

BWX Technologies announced today plans to expand and add advanced manufacturing equipment to its manufacturing plant in Cambridge, Ontario, Canada.A $36.3 million USD ($50M CAD) expansion will...

Taking aim at disease

Radioisotopes target cancer, improve imaging, and have myriad other medical uses

February 16, 2024, 3:02PMNuclear NewsKristi Nelson Bumpus

On August 2, 1946, 1 millicurie of the isotope carbon-14 left Oak Ridge National Laboratory, bound for the Barnard Free Skin and Cancer Hospital in St. Louis, Mo.That tiny amount of the...